Perlich Irene 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Jan 18, 2024
Insider Transaction Report
Form 4
Perlich Irene
Principal Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-01-16$1.34/sh−1,025$1,374→ 8,975 total
Footnotes (1)
- [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.